Mitchell & Pahl Private Wealth LLC raised its position in Equifax Inc. (NYSE:EFX – Free Report) by 6.0% during the fourth quarter, Holdings Channel reports. The fund owned 3,112 shares of the credit services provider’s stock after acquiring an additional 176 shares during the period. Mitchell & Pahl Private Wealth LLC’s holdings in Equifax were worth $793,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp increased its position in shares of Equifax by 1.1% during the 3rd quarter. State Street Corp now owns 4,816,186 shares of the credit services provider’s stock valued at $1,415,284,000 after purchasing an additional 52,489 shares during the last quarter. FMR LLC grew its position in Equifax by 37.4% during the third quarter. FMR LLC now owns 3,233,744 shares of the credit services provider’s stock valued at $950,268,000 after buying an additional 880,162 shares during the period. Geode Capital Management LLC increased its holdings in Equifax by 1.0% during the third quarter. Geode Capital Management LLC now owns 2,885,661 shares of the credit services provider’s stock valued at $845,041,000 after buying an additional 29,742 shares during the last quarter. International Assets Investment Management LLC raised its position in Equifax by 76,913.8% in the third quarter. International Assets Investment Management LLC now owns 960,362 shares of the credit services provider’s stock worth $282,212,000 after acquiring an additional 959,115 shares during the period. Finally, Franklin Resources Inc. boosted its stake in shares of Equifax by 34.2% during the 3rd quarter. Franklin Resources Inc. now owns 863,718 shares of the credit services provider’s stock worth $251,480,000 after acquiring an additional 220,109 shares during the last quarter. 96.20% of the stock is owned by hedge funds and other institutional investors.
Equifax Stock Performance
Shares of NYSE EFX opened at $262.87 on Tuesday. The company has a market cap of $32.58 billion, a P/E ratio of 58.42, a P/E/G ratio of 2.69 and a beta of 1.57. Equifax Inc. has a 52-week low of $213.02 and a 52-week high of $309.63. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.88 and a current ratio of 0.88. The firm’s fifty day moving average is $257.92 and its two-hundred day moving average is $273.66.
Equifax Dividend Announcement
Insider Buying and Selling
In other Equifax news, EVP John J. Kelley III sold 1,000 shares of Equifax stock in a transaction on Friday, October 25th. The shares were sold at an average price of $272.92, for a total value of $272,920.00. Following the completion of the transaction, the executive vice president now directly owns 11,269 shares of the company’s stock, valued at $3,075,535.48. This trade represents a 8.15 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Lisa M. Nelson sold 551 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $260.39, for a total transaction of $143,474.89. Following the completion of the sale, the executive vice president now owns 11,697 shares in the company, valued at approximately $3,045,781.83. This trade represents a 4.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 59,855 shares of company stock worth $16,187,044. Corporate insiders own 1.66% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on EFX shares. Needham & Company LLC restated a “buy” rating and issued a $350.00 price objective on shares of Equifax in a research note on Monday, October 28th. Robert W. Baird upped their price target on Equifax from $290.00 to $333.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. JPMorgan Chase & Co. lowered their price objective on Equifax from $304.00 to $283.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 19th. Oppenheimer cut their price objective on Equifax from $315.00 to $286.00 and set an “outperform” rating for the company in a research note on Tuesday, November 19th. Finally, UBS Group initiated coverage on shares of Equifax in a research note on Tuesday, October 1st. They set a “buy” rating and a $360.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $311.12.
Read Our Latest Report on Equifax
Equifax Profile
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
See Also
- Five stocks we like better than Equifax
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Compound Interest and Why It Matters When Investing
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFX – Free Report).
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.